HealthMore in Health→
Daiichi Sankyo Takes Nearly $1 Billion Hit After Pulling Back ADC Capacity Plans
Key Takeaways
- Daiichi Sankyo reported an extraordinary loss of 149.4 billion yen, roughly $950 million.
- The loss was tied to overestimating demand for antibody-drug conjugate manufacturing capacity.
- The company is scrapping plans to build that capacity, marking a notable strategic reversal.
DE
DT Editorial Team··via endpoints.news